Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S., F.C.P.S., Fellowship in Diabetes/Endocrine & Metabolism
Internal Medicine Specialist
M.B.B.S., F.C.P.S., Fellowship in Diabetes/Endocrine & Metabolism
Consultant Physician
MBBS, FCPS (Internal Medicine), Certified Diabetologist from International Diabetes Federation
Consultant Physician
MBBS, FCPS (Internal Medicine), Certified Diabetologist from International Diabetes Federation
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Diabetologist
MBBS, Diploma in Diabetes (Diabetes)
Internal Medicine Specialist
M.B.B.S.
Internal Medicine Specialist
MBBS, FCPS, MCPS, M.D (Cert. USA)
Consultant Physician
MBBS (Dow), MRCP (UK) , M.D (USA)
Diabetologist
MBBS, M.D
Diabetologist
M.B.B.S, Diploma in Diabetes
General Physician
MBBS, FCPS
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures